Preamble

Definition
A specialized residency in pharmacotherapy practice is defined as an organized, directed postgraduate program that centers on developing a mastery of knowledge and an expert level of competency in pharmacotherapy. Pharmacotherapy specialists assure the safe, appropriate, and economical use of medications in patients through the application of specialized skills, knowledge, and functions in patient care. A specialized residency in pharmacotherapy should be a minimum of 12 months in length (or integrated with a Pharmacy Practice Residency for a total of 24 months) and is designed to build on those competencies developed by a Residency in Pharmacy Practice.
Purpose and Philosophy
The supplemental residency standard establishes criteria for the training and education of pharmacists to deliver exemplary pharmacotherapy to patients. A pharmacotherapy practice residency embraces the concept that pharmacotherapy practitioners share in the responsibility and accountability for optimal medication therapy outcomes. Therefore, residencies in pharmacotherapy practice must provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and transforming it into improved medication therapy for patients. A resident who completes an accredited residency in pharmacotherapy practice should possess competencies that enable attainment of board certification as a pharmacotherapy specialist.
Accreditation Authority
The "ASHP Accreditation Standard for Specialized Pharmacy Residency Training," 1 together with this supplement, provides the basic criteria used to evaluate pharmacotherapy practice residency programs applying for accreditation by ASHP. Where a difference in criteria exists between these two documents, those contained in this supplement shall prevail.
Qualifications of the Training Site
The training site must meet the requirements set forth in Part I of the "ASHP Accreditation Standard for Specialized Pharmacy Residency Training." 1 Facilities may include, but are not limited to, health systems or tertiary care medical centers, ambulatory care settings, or general hospitals that provide extensive acute and chronic patient care services where pharmaco-PHARMACOTHERAPY RESIDENCY STANDARDS ASHP-ACCP therapy specialists function as professionals on the health care team and have been delegated responsibility for assuring the safe, appropriate, and economical use of medications.
Qualifications of the Pharmacy Service
When the residency is conducted as part of a pharmacy in a health system, the pharmacy services must meet the requirements set forth in Part IV of the "Accreditation Standard for Specialized Pharmacy Residency Training," 1 including the provision of comprehensive clinical pharmacy services. The residency program must provide the following training components:
• availability of comprehensive pharmacotherapy experiences in patients with acute and chronic diseases from a variety of patient populations (e.g., internal medicine, surgery, pediatrics, psychiatry, geriatrics); • active participation as a professional on the health care team; • patient interviewing and counseling; • interpretation and application of pharmacokinetic data and principles to patient care; • participation in the creation and dissemination of new knowledge in pharmacotherapy; • provision of patient-and population-specific drug information to health professionals and patients; • participation in medication-use evaluations, in quality improvement activities, and on appropriate institutional committees.
Qualifications of the Program Director
The program director' s qualifications shall meet the requirements set forth in Part II of the "ASHP Accreditation Standard for Specialized Pharmacy Residency Training." 1 The program director must be a clinical pharmacist with demonstrated expertise in pharmacotherapy practice, as exemplified by the following: (a) specialty residency training followed by a minimum of 3 years of practice experience or equivalent (i.e., 5 years of practice experience); (b) board certification in Pharmacotherapy; and (c) maintenance of an active patient-care service. The program director should participate in professional pharmacy associations appropriate to his or her area of practice. Other pharmacist preceptors must be able to demonstrate pharmacotherapy expertise in the area for which they serve as a preceptor.
Selection and Qualifications of the Resident
The resident must meet the requirements set forth in the "ASHP Accreditation Standard for Specialized Pharmacy Residency Training." 1 The pharmacotherapy residency program is designed to train highly committed pharmacists to provide exceptional pharmacy services in their area of practice. It is not intended to provide general pharmacy practice competencies but to build on such experiences to create a pharmacotherapy specialist. To this end, residency candidates must have earned a Doctor of Pharmacy degree and previously must have completed an ASHPaccredited pharmacy practice residency if entering into a 12-month residency program (or in the absence of these qualifications, the residency program director must demonstrate and document that the resident possesses the knowledge, skills, and abilities of a pharmacist who has completed a pharmacy practice residency). In cases where shortcomings in these qualifications are noted, the training program must include goals and objectives to address the shortcomings. The resident should participate in professional pharmacy associations appropriate to his or her area of practice.
Content of the Residency Program
The residency in pharmacotherapy practice shall be predicated on the knowledge, skills, and abilities required for an expert level of pharmacotherapy practice. The practice site offering the program shall provide an exemplary training environment; further, the scope of services at the site must be adequate to make possible the attainment of the residency goals and objectives set forth below.
Goals are general, broad statements about the knowledge, skills, and abilities expected of program graduates. Sometimes referred to as outcome competencies, goal statements convey the philosophical base upon which the educational objectives subsequently are built.
Educational objectives (terminal objectives and enabling objectives) specify observable, measurable behaviors. Terminal objectives (TOs) are the basis for objectively assessing resident performance. The TOs listed under each goal specify behaviors which, in sum, assure goal mastery and, therefore, must be formally assessed when a goal has been selected for active teaching and evaluation. Enabling objectives (EOs) represent learning required to master the TO under which they are listed. Enabling objectives are provided only to assist in identifying learning associated with achieving a goal's terminal objectives. Having this learning spelled out is of use in designing instruction. Enabling objectives should not be formally assessed.
An accredited residency in pharmacotherapy practice shall develop the pharmacist's competence to practice in a wide variety of practice settings. However, the following goals and objectives were written to include practice in all settings (e.g., acute care, ambulatory care, subacute care, home health care, nursing home care), and not all residency sites will have patients from all of these settings. Variability also will exist in the entering skills of trainees. Therefore, although all of the goals listed below must be included, variability among programs is expected due to the emphasis placed on these goals in order to meet the overall goals of the residency program and the needs of the institution sponsoring the residency program. The residency program director must assess and document the level of knowledge, skills, and abilities of the entering resident and develop a customized plan that ensures that the resident is able to demonstrate competence in all of the goals and objectives by the end of the residency.
For additional background and guidance on the use of goals and educational objectives, refer to The Residency Learning System (RLS) Model, 2 The Preceptor' s Guide to the RLS Model, 3 and The Resident' s Guide to Learning through the RLS. 4 
Pharmacotherapy Practice Residency Goal Statements
Practice Foundation Skills Goal S1: Take personal responsibility for attaining excellence in one' s own ability to provide pharmacotherapy. Goal S2: Understand the role of the pharmacotherapy specialist in leading others to excellence in the practice of pharmacotherapy. 
Participate in Developing and Evaluating Medication-Use Policies
Goal I5: Provide pharmacotherapy expertise to the health system in the development of its medication use, patient care, and research-related policies. Goal I6: Assume responsibility for the health system's ongoing adherence to its medication-use policies. Goal I7: Generate and disseminate new knowledge in pharmacotherapy (e.g., review article, case report or series, original research).
Practice Management
Develop Personal Practice Management Skills
Goal M1: Understand the process for establishing a pharmacotherapy specialty residency in one' s own health system. Goal M2: Work through the political and decision-making structure to accomplish one' s practice area goals. Goal M3: Prioritize job responsibilities.
Manage Integrated Pharmaceutical Care Services
Goal M4: Evaluate current pharmacy services to determine if the services are meeting the health care needs of the patients. Goal M5: Enhance the skills of pharmacy technicians, pharmacy students, pharmacy residents, or pharmacists. Goal M6: Understand the conduct and use of prospective and retrospective financial and clinical outcomes analyses. Goal M7: Understand how to document and justify clinical services. Goal M8: Understand the practices and processes that allow direct billing to third-party payers for patient care services provided by pharmacists.
Goal Statements with Associated Terminal and Enabling Objectives
Practice Foundation Skills Goal S1: Take personal responsibility for attaining excellence in one' s own ability to provide pharmacotherapy. TO S1.1 (Characterization) Use a systematic, ongoing process to self-assess and meet learning needs. TO S1.2 (Characterization) Adhere to an efficient system for arranging and storing information related to one' s practice. Goal S2: Understand the role of the pharmacotherapy specialist in leading others to excellence in the practice of pharmacotherapy. TO S2. 
